SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-10-002283
Filing Date
2010-02-08
Accepted
2010-02-08 16:16:47
Documents
1
Period of Report
2010-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4047
  Complete submission text file 0001179110-10-002283.txt   5917
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 ELLIOTT AVE W STE 500 SEATTLE WA 981194114
Business Address
JACKSON MICHAEL K (Reporting) CIK: 0001287535 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 10581130